sevoflurane has been researched along with Acquired Nephrogenic Diabetes Insipidus in 5 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We hereby report 3 cases of nephrogenic diabetes insipidus associated with prolonged sevoflurane sedation using the AnaConDa device and review the possible mechanisms of renal toxicity." | 1.51 | Complete Nephrogenic Diabetes Insipidus After Prolonged Sevoflurane Sedation: A Case Report of 3 Cases. ( Cabibel, R; Collin, V; Gerard, L; Hantson, P; Maiter, D, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reins, J | 1 |
| Balling, F | 1 |
| Baader, C | 1 |
| Böck, E | 1 |
| Schöniger, W | 1 |
| van Erp, R | 1 |
| Eff, S | 1 |
| Hafner, S | 1 |
| Honore, PM | 1 |
| De Bels, D | 1 |
| Barreto Gutierrez, L | 1 |
| Redant, S | 1 |
| Gallerani, A | 1 |
| Boer, W | 1 |
| Coppola, S | 1 |
| Cenci, S | 1 |
| Cozzolino, M | 1 |
| Chiumello, D | 1 |
| Cabibel, R | 1 |
| Gerard, L | 1 |
| Maiter, D | 1 |
| Collin, V | 1 |
| Hantson, P | 1 |
| L'Heudé, M | 1 |
| Poignant, S | 1 |
| Elaroussi, D | 1 |
| Espitalier, F | 1 |
| Ferrandière, M | 1 |
| Laffon, M | 1 |
5 other studies available for sevoflurane and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
[Nephrogenic diabetes insipidus after inhalation sedation with sevoflurane in a patient with COVID-19-associated acute respiratory distress syndrome].
Topics: Anesthetics, Inhalation; COVID-19; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Humans; Pneum | 2023 |
Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue?
Topics: Diabetes Insipidus, Nephrogenic; Glycopeptides; Humans; Hypernatremia; Sevoflurane | 2019 |
Sevoflurane sedation and nephrogenic diabetes insipidus in patients affected with severe acute respiratory syndrome coronavirus 2.
Topics: Anesthesia; Anesthetics, Inhalation; COVID-19; Diabetes Insipidus, Nephrogenic; Humans; Hypnotics an | 2021 |
Complete Nephrogenic Diabetes Insipidus After Prolonged Sevoflurane Sedation: A Case Report of 3 Cases.
Topics: Adult; Anesthetics, Inhalation; Diabetes Insipidus, Nephrogenic; Drug Administration Schedule; Human | 2019 |
Nephrogenic diabetes insipidus associated with prolonged sedation with sevoflurane in the intensive care unit.
Topics: Adult; Aged; Anesthetics, Inhalation; Conscious Sedation; Critical Care; Diabetes Insipidus, Nephrog | 2019 |